Found: 33
Select item for more details and to access through your institution.
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00990-3
- By:
- Publication type:
- Article
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00989-w
- By:
- Publication type:
- Article
Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 8211, doi. 10.1007/s00520-022-07280-3
- By:
- Publication type:
- Article
Front line treatment of elderly multiple myeloma in the era of novel agents.
- Published in:
- Biologics: Targets & Therapy, 2009, v. 3, p. 99
- By:
- Publication type:
- Article
Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 780, doi. 10.1111/bjh.18290
- By:
- Publication type:
- Article
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA).
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 203, doi. 10.1111/bjh.18198
- By:
- Publication type:
- Article
Low incidence of hyperacute graft‐versus‐host disease (GVHD) with effective GVHD prophylaxis based on anti‐thymocyte globulin.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 5, p. 630, doi. 10.1111/bjh.18099
- By:
- Publication type:
- Article
Allogeneic haematopoietic cell transplantation for myelofibrosis: a real‐life perspective.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 4, p. 495, doi. 10.1111/bjh.17469
- By:
- Publication type:
- Article
Infectious complications after post‐transplantation cyclophosphamide and anti‐thymocyte globulin‐based haploidentical stem cell transplantation.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. e64, doi. 10.1111/bjh.16189
- By:
- Publication type:
- Article
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E312, doi. 10.1002/ajh.26626
- By:
- Publication type:
- Article
Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 934, doi. 10.1002/ajh.26209
- By:
- Publication type:
- Article
Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 11, p. 2787, doi. 10.1007/s00277-021-04640-7
- By:
- Publication type:
- Article
Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 467, doi. 10.1111/ejh.13568
- By:
- Publication type:
- Article
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 19, p. 3602, doi. 10.1002/cam4.4742
- By:
- Publication type:
- Article
Novel M-component based biomarkers in Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 164, doi. 10.3816/CLML.2011.n.039
- By:
- Publication type:
- Article
Impact of cyclosporine A concentration on acute graft‐vs‐host disease incidence after haploidentical hematopoietic cell transplantation.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 1, p. 10, doi. 10.1111/ejh.13233
- By:
- Publication type:
- Article
Update on therapeutic options in Waldenström macroglobulinemia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 1, p. 1, doi. 10.1111/j.1600-0609.2008.01171.x
- By:
- Publication type:
- Article
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Checkpoint Inhibition Before Haploidentical Stem Cell Transplantation in Relapsed or Refractory Hodgkin Lymphoma (Hl) Patients is Associated with Higher PFS without Increased Toxicities.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S306, doi. 10.1016/j.clml.2019.07.270
- By:
- Publication type:
- Article
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- Journal of Clinical Immunology, 2024, v. 44, n. 6, p. 1, doi. 10.1007/s10875-024-01741-6
- By:
- Publication type:
- Article
Early <sup>18</sup>F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.232827
- By:
- Publication type:
- Article
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00534-z
- By:
- Publication type:
- Article
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00518-z
- By:
- Publication type:
- Article
High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 9, p. 1, doi. 10.1002/cti2.1171
- By:
- Publication type:
- Article
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 11, p. 1332, doi. 10.1080/0284186X.2022.2130709
- By:
- Publication type:
- Article
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3952, doi. 10.1002/cncr.28946
- By:
- Publication type:
- Article
A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1410638
- By:
- Publication type:
- Article
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 3, p. 230, doi. 10.1159/000528184
- By:
- Publication type:
- Article
Hidden in the Eyes—Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 3, p. 456, doi. 10.3390/medicina58030456
- By:
- Publication type:
- Article